SAUDI-ECONOMY-PLANNING
19.1.2024 08:10:31 CET | Business Wire | Press release
Saudi Arabia is prioritizing peace and prosperity in its efforts to lead the Middle East towards stability and security amid ongoing geopolitical volatility in the region, the World Economic Forum (WEF) Annual Meeting 2024 heard today from Her Royal Highness Princess Reema Bandar Al-Saud, Ambassador of the Kingdom of Saudi Arabia to the United States of America.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240118880673/en/
Saudi Ambassador to US says Kingdom prioritizing ‘peace and prosperity’ policies at the World Economic Forum 2024 (Photo: AETOSWire)
“The Kingdom has not put normalization at the heart of its policy. It’s put peace and prosperity at the heart of its policy,” she said in a session on ‘Saudi Arabia: The Course Ahead’.
HRH Princess Reema emphasized Saudi Arabia’s focus on the “Palestinian people who deserve a state, sovereignty, and a pathway that is irrevocable. That is how we get security. We carry peace, we carry prosperity, we carry safety, and we deliver it through the Palestinian statehood.”
In the same session, His Excellency Adel A. Aljubeir, Saudi Arabia’s Minister of State for Foreign Affairs, Member of the Council of Ministers and Envoy for Climate, spoke of the need to address climate change scientifically, decoupled from emotions and hypocrisy.
“The world’s appetite for energy is unlimited. The additional increase of energy supplies has to come from non-oil resources,” Aljubeir said, noting that, “We are saying we have a problem, and the problem has to do with climate change. And we need to tackle this problem in a serious, scientific manner. We need to deal with it without emotions, we need to deal with it without trying to score political points.”
His Excellency Mohammed Aljadaan, Saudi Arabia’s Minister of Finance, emphasized that the Kingdom is determined to double down on what it is doing on its economy because the region and the world need a strong Saudi.
Aljadaan highlighted that the Kingdom’s non-oil GDP is growing, unemployment is at the lowest level, and women's participation in the workforce has already surpassed the target set under the Saudi Vision 2030.
In an earlier session on ‘MENA’s Economic Dilemma: Reforms Amid Uncertainty’, His Excellency Faisal F. Alibrahim, Saudi Arabia’s Minister of Economy and Planning, described the resilient nature of the region. He said the Middle East “always comes out of challenges as a better version of itself” adding that it has an opportunity to “co-author the future of the global economy”.
Alibrahim touched on national transformations, highlighting the importance of delivering “consistently with a boldness and a view to collaborate with the world. Vision 2030 is an evolution, a transformation that is taking us to where we want to be as an economy and society.”
In the morning, a session on ‘Ocean Regeneration Through Collaborative Innovation’ explored approaches and solutions to environmental challenges.
*Source: AETOSWire
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240118880673/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Takeda Receives U.S. FDA Approval of MIMRYLO™ (rusfertide), Marking a Potential Shift in the Treatment Paradigm for Polycythemia Vera29.8.2026 00:40:00 CEST | Press release
MIMRYLO, a First-in-Class Medicine with a Unique Mechanism of Action, is Approved for the Treatment of Erythrocytosis in Adults with Polycythemia Vera (PV)MIMRYLO Has Been Shown to Maintain Hematocrit Control, the Primary Treatment Goal in PV, as Well as Reduce Phlebotomy Burden and Improve FatigueApproval Supported by Phase 3 VERIFY Results Showing 76.9% of Patients Achieved Clinical Response During Weeks 20-32 Takeda (TSE:4502/NYSE:TAK)announced U.S. Food and Drug Administration (FDA) approval of the New Drug Application (NDA)* for MIMRYLO™ (rusfertide) for the treatment of erythrocytosis in adults with polycythemia vera (PV), a blood cancer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260824773270/en/ MIMRYLO Logo MIMRYLO is a first-in-class hepcidin mimetic designed to regulate iron distribution in the body and red blood cell overproduction to control hematocrit levels, which is the ratio of red blood cells to the tot
Rigaku and Tohoku University Establish a New Research Institute for X-Ray Metrology28.8.2026 16:00:00 CEST | Press release
Rigaku Corporation, a group company of Rigaku Holdings and a global solutions partner for X-ray analytical systems (Head Office: Akishima, Tokyo; President and CEO: Jun Kawakami; “Rigaku”), and Tohoku University (Sendai, Miyagi; President: Teiji Tominaga; “Tohoku University”) have established the Rigaku-Tohoku University Co-Creation Research Institute for X-ray Metrology: Beyond The Limits (the “Institute”) at Tohoku University on August 1, 2026. The Institute will advance X-ray metrology technology, develop new metrology methods, and foster the next generation of researchers through an initial three-year collaboration, with the possibility of extension based on its achievements. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828688510/en/ Inside the Institute As semiconductors become smaller, more multilayered, and incorporate a wider range of materials, manufacturing processes are becoming increasingly complex. X-ray me
BLK: Portfolio Company of Enry’s Island S.p.A., Lists on Euronext Dublin28.8.2026 15:34:00 CEST | Press release
Enry’s Island S.p.A. (WBAG:EIOS), an international venture builder with headquarters in the Tremiti Islands and the Metaverse, announces that BLK Global PLC, one of the portfolio companies within its ecosystem, has successfully completed its admission to trading on Euronext Access Dublin. Trading in the company’s shares commenced on Friday, July 31, 2026, under ticker BLKX and ISIN GB00BPSKS130. BLK was one of the thousands of applications received by Enry’s Island which, following an assessment process based on the Enry’s Model, was selected for a one-year incubation and acceleration programme. The programme supported the company through its subsequent growth stages, ultimately leading to its current stock market listing. Alessandro Pacciana, Investor Relations Manager of Enry’s Island S.p.A., said: “BLK’s listing is the second stock market listing in two years among Enry’s Island’s portfolio companies, while Enry’s Island itself is the world’s first listed venture builder. We are pro
Zambon Announces European Commission Approval of Hopledo® for Adults with Parkinson's Disease and Moderate to Severe Motor Fluctuations28.8.2026 11:00:00 CEST | Press release
Hopledo® is a first-in-class, oral, modified-release formulation of levodopa/carbidopa (LD/CD) approved for the treatment of motor fluctuations of Parkinson’s disease Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026 The approval is based on data from the Phase 3 RISE-PD trial where Hopledo® demonstrated a significant increase in Good ON time compared with immediate-release LD/CD with fewer daily doses and a comparable safety profile Zambon today announced that the European Commission (EC) has granted marketing authorization for Hopledo® (modified-release levodopa/carbidopa) for the treatment of adult patients with Parkinson’s disease and moderate to severe motor fluctuations who have not been sufficiently stabilized with oral levodopa/dopa decarboxylase (DDC) inhibitor-based treatment regimens. Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026. The company is working closely
MTG-I2 Safely in Orbit, Unlocking Faster and Sharper Weather Monitoring Across Europe28.8.2026 10:16:00 CEST | Press release
The Meteosat Third Generation Imager 2 satellite (MTG-I2) has successfully passed its first critical post-launch milestones, completing the first full Meteosat Third Generation constellation in orbit. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828243790/en/ Credit: Arianespace livestream The imager satellite MTG-I2 is safely in orbit and operating as expected following its successful launch yesterday at 22:11 CEST on board an Ariane 6 rocket from Europe’s Spaceport in French Guiana. Our teams have established communication with the spacecraft, which has also deployed its solar panels to ensure its autonomous production of energy. MTG-I2 is in perfect shape to start its Launch and Early Operations Phase that will bring it to a higher orbit, 36 000km above Earth over the following two weeks, where a longer period of calibration and validation of its instruments will begin. This summer’s extreme weather and wildfires hav
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom